This chemical is primarily utilized in pharmaceutical research and development, particularly in the synthesis of bioactive compounds and drug candidates. Its structure, featuring a piperazine ring and a benzylamine group, makes it a valuable intermediate in the design of molecules targeting central nervous system disorders, such as antipsychotic and antidepressant agents. Additionally, it is employed in the creation of ligands for receptor binding studies, aiding in the exploration of neurological pathways. Its versatility also extends to the development of compounds with potential antimicrobial or anticancer properties, where its functional groups can be modified to enhance activity and selectivity.